| |
| |
|
| Insider
Information: |
Dulac Edward J Iii |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
101,479 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$375,472 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
101,479 |
|
|
| Total
Value |
$375,472 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fate Therapeutics Inc |
FATE |
|
2024-03-04 |
101,479 |
2020-08-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FATE |
Fate Therapeutics Inc |
Chief Financial Officer |
• – – |
2024-03-04 |
4 |
AS |
$7.77 |
$19,013 |
D/D |
(2,447) |
101,479 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Chief Financial Officer |
• – – |
2024-01-29 |
4 |
AS |
$5.00 |
$9,245 |
D/D |
(1,849) |
103,926 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Chief Financial Officer |
• – – |
2024-01-09 |
4 |
S |
$4.37 |
$30,712 |
D/D |
(7,028) |
105,775 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Chief Financial Officer |
• – – |
2024-01-02 |
4 |
AS |
$3.66 |
$18,966 |
D/D |
(5,182) |
112,803 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-12-18 |
4 |
AS |
$3.50 |
$5,548 |
D/D |
(1,585) |
117,985 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-08-18 |
4 |
S |
$2.80 |
$13,210 |
D/D |
(4,718) |
119,570 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-07-05 |
4 |
AS |
$4.83 |
$25,029 |
D/D |
(5,182) |
124,288 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-01-10 |
4 |
S |
$5.24 |
$38,414 |
D/D |
(7,331) |
129,470 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-08-18 |
4 |
S |
$29.75 |
$153,051 |
D/D |
(5,135) |
136,801 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
33,302 |
141,936 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-01-11 |
4 |
S |
$48.25 |
$85,757 |
D/D |
(1,770) |
108,634 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-12-20 |
4 |
AS |
$60.00 |
$958,620 |
D/D |
(15,977) |
110,404 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-12-20 |
4 |
OE |
$35.52 |
$512,802 |
D/D |
14,437 |
126,381 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-09-28 |
4 |
AS |
$62.53 |
$1,216,834 |
D/D |
(19,460) |
52,404 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-09-28 |
4 |
OE |
$35.52 |
$615,384 |
D/D |
17,325 |
71,864 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-08-19 |
4 |
S |
$87.90 |
$306,602 |
D/D |
(3,474) |
54,539 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
18,013 |
58,013 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
40,000 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
